药物开发过程:提高效率和成本效益 328条(本栏目收费,不能显示细节,电话13136136841)
laboratory at Zeneca, 388-394, 401-404, 408-411, 415 415
and preclinical studies, 379-380 380
role in drug development process, 379-384 384
support of Phase I trials, 394-395 395
11. Clinical Pharmacology in Drug Development: A View to Future Effectiveness J. Robert Powell, Alan Bye, and Paul D. Rubin 295
12. Contracting CROs into Your Organization: New Strategies for New Challenges Gary D. Lightfoot and John R. Vogel 317
13. The Role of Clinical Research Organizations in Drug Development Albert J. Siemens and James E. Higgins 377
Part VII: European and Japanese Approaches 0
14. Understanding Drug Development and Registration in Japan W. J. C. Currie 353
15. Increasing the Effectiveness of Clinical Pathology Testing and Its Value to Drug Development in Europe Dai Davies and Karolyn Jackson 377
16. New Marketing Authorization Procedures in the European Union and the Impact on Regulatory Strategy Vaila M. Marshall 421
ACE inhibitors, 20, 24, 26, 28 28
Action Potential Duration (APD), 23 23
Anticancer drugs, 282-293 293
animal toxicology of, 284-285 285
dose escalation schemes, 287-289 289
phase I trials, 285-290 290
phase II trials, 290-291 291
phase III trials, 291-292 292